Status | Study |
Recruiting |
Study Name: Myotonic Dystrophy Family Registry Condition: Myotonic Dystrophy Congenital Myotonic Dystrophy Myotonic Date: 2015-03-06 Interventions: Other: Patient-entered data This registry provides patient-entered data for future clinical trial and st |
Completed |
Study Name: Mexiletine and Non Dystrophic Myotonias Condition: Non-dystrophic Myotonias Paramyotonia Congenita Date: 2015-01-08 Interventions: Drug: Mexiletine |
Recruiting |
Study Name: Study of Ranolazine in Myotonia Congenita, Paramyotonia Congenita and Myotonic Dystrophy Type 1 Condition: Myotonia Congenita (Enrollment Complete) Paramyotonia Congenita Date: 2014-09-25 Interventions: Drug: Ranolazine Ranexa is FDA approved for chronic angina |
Completed |
Study Name: Relations Between Myotonia and Fitness Condition: Congenital Myotonia Date: 2014-06-06 Interventions: Other: Training 30 minutes of home based pulse watch regulated cycle-ergometer exercise, three times a w |
Completed |
Study Name: Combined N-of-1 Trials Mexiletine vs Placebo in Patients With Non-Dystrophic Myotonia (NDM) Condition: Non Dystrophic Myotonia Date: 2013-11-18 Interventions: Drug: Mexiletine |
Completed |
Study Name: Lamotrigine as Treatment of Myotonia Condition: Dystrophia Myotonica Type 1 Myotonia Congenita Date: 2013-08-23 Interventions: Drug: Lamotrigine Other Name: |
Completed |
Study Name: Effectiveness of Mexiletine for Treating People With Non-Dystrophic Myotonia Condition: Myotonia Non-Dystrophic Myotonia Date: 2009-01-27 Interventions: Drug: Mexiletine 200 mg three |
Recruiting |
Study Name: Cardiovascular Consequences of NIV Withdrawal in Patients With Myotonic Dystrophy Condition: Myotonia Date: 2008-09-01 Interventions: Other: withdrawal of non-invasive ventilation Four weeks withdrawal of non-invasive ventilation |
Completed |
Study Name: Characteristics of Nondystrophic Myotonias Condition: Nondystrophic Myotonias Myotonia C Date: 2005-10-24 |